Pharmaceutical major Lupin today said its consolidated net profit for the third quarter ended December 31, declined by 35.58 per cent to Rs 116.50 crore.
The company had a net profit of Rs 180.86 crore for the same quarter in the last financial year, Lupin said in a filing to the Bombay Stock Exchange.
Total income of the company rose to Rs 983.68 crore for the quarter under review, against Rs 856.25 crore in the same period last year.
"The past 10 quarters have been noteworthy. We have continued to outpace and outperform across business segments and markets consistently having steadily consolidated our footprint globally," Lupin Managing Director Kamal Sharma said.
For the nine month ended December 31, the company has a net profit of Rs 344.16 crore, against Rs 312.38 crore in the same period last year.
